Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Newsletter
CEI Daily Update
Issues in the News 1. Congress Energy legislation appears to be stalling out in the Senate. CEI Expert Available…
Op-Eds
Junk Science: Military Suicide Mystery
Researchers and the media did their best this week to scare military personnel and their families with the widely reported headline, “Military Service Doubles…
Newsletter
Cooler Heads Digest
1. Global Warming in the News 2. CEI’s Insider Info 3. Issue of the Week: Price Gouging 4. Action Item: Join the…
Op-Eds
Al Gore: The Edge of Reason
Review: THE ASSAULT ON REASON by Al Gore, Penguin Press, $25.95, 320 pages Al Gore may be the most frustrated man in…
Newsletter
CEI Daily Update
Issues in the News 1.Legal The Supreme Court rules against Philip Morris as part of an on-going legal fight…
Op-Eds
Stubborn FDA harms arthritis sufferers
Helvetia, W.Va. – The Food And Drug Administration’s (FDA) safety alert for the popular diabetes drug Avandia has gotten headlines recently, but its…